Clinical Study
Serum Fructosamine, Total Cholesterol, and High-Density Lipoprotein in Children with Asthma during Glucocorticoid Treatment
Table 2
Serum fructosamine, total cholesterol, and HDL during active and placebo/no treatment presented as mean (SEM).
| Prednisolone trial | Prednisolone | Placebo | P-value | 95% Cl2 |
| Serum fructosamine/μM1 | 252.3 [4.1] | 247.3 [3.5] | 0.03 | 0.7 to 9.3 | Total cholesterol/mM1 | 4.14 [0.16] | 4.00 [0.15] | 0.09 | −0.02 to 0.30 | HDL/mM1 | 1.43 [0.08] | 1.34 [0.07] | 0.06 | 0.00 to 0.17 |
| Budesonide trial | Budesonide | No treatment | P-value | 95% CI2 |
| Serum fructosamine/μM1 | 228.1 [3.3] | 223.1 [3.2] | 0.02 | 1.0 to 9.1 | Total cholesterol/mM1 | 3.99 [0.12] | 3.97 [0.13] | 0.76 | −0.17 to 0.23 | HDL/mM1 | 1.44 [0.08] | 1.41 [0.06] | 0.42 | −0.05 to 0.10 |
|
|